首页> 美国卫生研究院文献>Journal of Bacteriology >The rcsA gene of Escherichia coli O9:K30:H12 is involved in the expression of the serotype-specific group I K (capsular) antigen.
【2h】

The rcsA gene of Escherichia coli O9:K30:H12 is involved in the expression of the serotype-specific group I K (capsular) antigen.

机译:大肠杆菌O9:K30:H12的rcsA基因参与血清型特异性I K(荚膜)抗原的表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Escherichia coli produces two distinct types of capsular polysaccharide (designated groups I and II), which are distinguished by chemical, physical, and genetic characteristics. The K30 capsular antigen is a member of the group I, or heat-stable, capsules. We have cloned rcsA from E. coli O9:K30 and determined the nucleotide sequence. The rcsAK30 sequence is virtually identical to the rcsAK-12 sequence (V. Stout, A. Torres-Cabassa, M. R. Maurizi, D. Gutnick, and S. Gottesman, J. Bacteriol. 173:1738-1747, 1991). RcsAK-12 is a transcriptional activator involved in expression of the extracellular polysaccharide colanic acid in E. coli K-12. rcsAK30 complemented an rcsAK-12 mutation and activated colanic acid synthesis in E. coli K-12 strains. However, in E. coli K30, increasing the levels of RcsA by introducing multicopy rcsAK30 or a Lon mutation resulted in elevated synthesis of the K30 capsular polysaccharide; no colanic acid was detected. E. coli K-12 strains in which the chromosomal his region was replaced by that from E. coli K30 were able to synthesize K30 capsular polysaccharide. These K-12/K30 hybrid strains did not produce colanic acid, suggesting that the genes for synthesis of colanic acid and the K30 capsular polysaccharide may be allelic. rcsA sequences were also detected in the group II strains E. coli K1 and K5. Introduction of rcsAK30 into group II strains resulted in activation of colanic acid biosynthesis rather than the group II capsule. Given the role of RcsA in other members of the family Enterobacteriaceae, our results provide further evidence that this protein may be a relatively widespread regulatory component for the synthesis of enterobacterial extracellular polysaccharides.
机译:大肠杆菌产生两种不同类型的荚膜多糖(命名为I和II组),其特征在于化学,物理和遗传特征。 K30荚膜抗原是I组或热稳定胶囊的成员。我们已经从大肠杆菌O9:K30中克隆了rcsA,并确定了核苷酸序列。 rcsAK30序列实际上与rcsAK-12序列相同(V.Stout,A.Torres-Cabassa,M.R.Maurizi,D.Gutnick,和S.Gottesman,J.Bacteriol.173:1738-1747,1991)。 RcsAK-12是一种转录激活因子,参与大肠杆菌K-12中细胞外多糖可乐酸的表达。 rcsAK30补充了rcsAK-12突变并激活了大肠杆菌K-12菌株中的可乐酸合成。但是,在大肠杆菌K30中,通过引入多拷贝rcsAK30或Lon突变来提高RcsA的水平会导致K30荚膜多糖合成的增加。没有检测到可乐酸。大肠杆菌K-12菌株中的染色体his区域被大肠杆菌K30的菌株所替代,能够合成K30荚膜多糖。这些K-12 / K30杂种菌株未产生可乐酸,表明合成可乐酸和K30荚膜多糖的基因可能是等位基因。在第二组菌株大肠杆菌K1和K5中也检测到了rcsA序列。将rcsAK30导入II组菌株可激活可乐酸的生物合成,而不是II组胶囊。考虑到RcsA在肠杆菌科其他成员中的作用,我们的结果提供了进一步的证据,表明该蛋白可能是肠细菌性细胞外多糖合成的相对广泛的调控成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号